Lage S G, Carvalho R T, Kopel L, Monachini M C, Bellotti G, Pileggi F
Instituto do Coração, Hospital das Clínicas, FMUSP.
Arq Bras Cardiol. 1994 Mar;62(3):155-7.
To evaluate the toxicity of thiocyanate induced by the infusion of sodium nitroprusside in patients with severe congestive failure.
We studied 23 patients with congestive heart failure, in class IV (NYHA) under continuous infusion of sodium nitroprusside with doses varying between 0.5 and 5.5 micrograms/kg/min. Clinical evaluation, thiocyanate serum dosage and laboratorial evaluation of renal, hepatic and pulmonary functions were done.
Seventeen patients (74%) presented toxic levels of thiocyanate (over 10 micrograms/ml), with the average of 29.9 +/- 4.4 micrograms/ml. Only renal function was related to the presence of intoxication. Clinical evaluation was not accurate to diagnose the thiocyanate toxicity in the patients.
Sodium nitroprusside is potentially toxic, especially when the renal function is abnormal. Thiocyanate dosage is useful in diagnosing nitroprusside induced toxicity and then it contributes to an adequate treatment and prevention of clinical toxicity.
评估硝普钠输注对重度充血性心力衰竭患者诱发硫氰酸盐的毒性。
我们研究了23例纽约心脏协会(NYHA)心功能IV级的充血性心力衰竭患者,持续输注硝普钠,剂量在0.5至5.5微克/千克/分钟之间。进行了临床评估、血清硫氰酸盐测定以及肾、肝和肺功能的实验室评估。
17例患者(74%)出现硫氰酸盐中毒水平(超过10微克/毫升),平均为29.9±4.4微克/毫升。只有肾功能与中毒的发生有关。临床评估对于诊断患者的硫氰酸盐毒性并不准确。
硝普钠具有潜在毒性,尤其是在肾功能异常时。硫氰酸盐测定有助于诊断硝普钠诱发的毒性,进而有助于进行适当的治疗和预防临床毒性。